Northeast Financial Consultants’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,000
Closed -$138K 294
2023
Q2
$138K Hold
10,000
0.01% 277
2023
Q1
$162K Hold
10,000
0.01% 302
2022
Q4
$177K Hold
10,000
0.01% 305
2022
Q3
$195K Hold
10,000
0.01% 313
2022
Q2
$199K Hold
10,000
0.01% 315
2022
Q1
$258K Hold
10,000
0.01% 328
2021
Q4
$253K Hold
10,000
0.02% 308
2021
Q3
$269K Hold
10,000
0.02% 295
2021
Q2
$319K Hold
10,000
0.02% 275
2021
Q1
$352K Hold
10,000
0.03% 247
2020
Q4
$321K Hold
10,000
0.03% 248
2020
Q3
$316K Hold
10,000
0.03% 225
2020
Q2
$356K Hold
10,000
0.03% 201
2020
Q1
$288K Hold
10,000
0.03% 205
2019
Q4
$235K Hold
10,000
0.02% 264
2019
Q3
$180K Hold
10,000
0.02% 307
2019
Q2
$157K Hold
10,000
0.02% 318
2019
Q1
$228K Hold
10,000
0.03% 278
2018
Q4
$233K Buy
+10,000
New +$267K 0.03% 139

Other funds holding PETS

Northeast Financial Consultants's PETS Position: Q3 2023 in Review

Northeast Financial Consultants sold out of PetMed Express (PETS) in Q3 2023, closing a stake of 10,000 shares — an estimated $138K sold.

Northeast Financial Consultants first reported a position in PETS in Q4 2018 and held it in 19 quarters. The position peaked at $356K in Q2 2020. 138 funds tracked by Wall St. Rank hold PETS as of Q3 2023.

  • Northeast Financial Consultants reported no remaining PetMed Express position as of Q3 2023 after selling out during the quarter.
  • Northeast Financial Consultants sold 10,000 PetMed Express shares in Q3 2023, an estimated $138K.
  • Northeast Financial Consultants first reported a position in PetMed Express in Q4 2018 and held it in 19 quarters.
  • Northeast Financial Consultants's PetMed Express position peaked at $356K in Q2 2020.
  • 138 funds tracked by Wall St. Rank held PetMed Express as of Q3 2023.

Based on Northeast Financial Consultants's 13F filing for Q3 2023, filed 14 Nov 2023.